Need professional-grade analysis? Visit stockanalysis.com
$25.39B
69.97
4,861
N/A
SUNSHINE LAKE PHARMA CO LTD (6887) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at HKD44.02, down 1.92% from the previous close.
Over the past year, 6887 has traded between a low of HKD40.46 and a high of HKD59.90. The stock has lost 26.5% over this period. It is currently 26.5% below its 52-week high.
SUNSHINE LAKE PHARMA CO LTD has a market capitalization of $25.39B, with a price-to-earnings ratio of 69.97.
Sunshine Lake Pharma Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology. It offers Kewei for the treatment of influenza; Dongweien for the treatment of hepatitis C; and generic drugs for the treatment of infections caused by sensitive bacteria, namely Clarithromycin, Levofloxacin, and Moxifloxacin Hydrochlorid, as well as active pharmaceutical ingredients. The company also engages in the wholesale, retail, import, and export of drugs. The company was formerly known as Sunshine Lake Pharma Ltd. The company was incorporated in 2001 and is based in Dongguan, China.
Side-by-side comparison against top Healthcare peers.